A Post-Authorisation Safety Study (PASS) to Assess the Effectiveness of the Risk Minimisation Measures of Domperidone – Physician Survey

First published 11/11/2016

Last updated 02/04/2024

EU PAS number:

EUPAS16095

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

PASS Study_DUS_Physician Survey_Domperidone_JNJ-17296812-AAA_0005_EDMS-ERI-90221144_8.0

English (355.1 KB - PDF)View document

Study results

Study results

Domperidone PASS Study RRA-17004_CSR_Final 27JUN2017

English (606.64 KB - PDF)View document

Study report

Other information